DocDollars

Scpharmaceuticals Inc.

MA · United States · Reporting entity ID 100001326929

Total reported 2019–2025
$3.54M
#829 of 2,960 reporting companies — 0% of all reported industry payments
$2.90M in general payments across 39,528 records, plus $642K in research funding across 6 records.

How it breaks down

General payments $2,896,008
Research funding $641,719

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Scpharmaceuticals Inc. reported $3.54M to US doctors and teaching hospitals from 2019 to 2025, ranking #829 of 2,960 reporting companies. 18% of that was research funding and 82% general payments such as consulting, speaking, food and travel. 39,528 general payment records and 6 research records were filed.

Common questions about Scpharmaceuticals Inc.

How much has Scpharmaceuticals Inc. paid US doctors?

Scpharmaceuticals Inc. reported $3,537,727 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,896,008 in general payments, $641,719 in research funding.

How does Scpharmaceuticals Inc. rank among drug and device companies?

It ranks #829 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Scpharmaceuticals Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.